Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modeling approach
Autoren
Xiong Y, Pigeolet E, Mulyukov Z, Margaron P, Racine A, Clemens A
Journal
Contemp Clin Trials
Veröffentlichungsdatum
2019
Impact Factor
2.640
Abstract
Weitere IDs
Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modeling approach - Publikation von Dr. Andreas Clemens | Dr. Andreas Clemens